October 5, 2021
Bayer to invest over €400 million to increase access to modern contraception
Bayer announced to invest over €400 million, reinforcing its commitment to providing 100 million women and girls with access to…
Pharmaceuticals, Biotechnology and Life Sciences
Tag: contraception
November 24, 2015
Lupin gets a go-ahead to market Blisovi – generic version Warner Chilcott’s Loestrin tablets – in U.S.
US FDA has given Lupin a go to market Blisovi Fe 1/20 Tablets and Blisovi 1.5/30 Tablets market generic versions of Warner Chilcott’s Loestrin Fe 1/20 Tablets and Loestrin Fe 1.5/30 Tablets.
November 20, 2015
Bayer submits its new five-year-contraceptive for EU and US marketing Authorization
Bayer has submitted an application for marketing authorization in both the European Union and in the United States for LCS-16, a new low-dose levonorgestrel-releasing intrauterine system